We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
no probs Nat, non taken!
well if we work on Align metrics then this will be around 45p when the 20k tests come online? Should be around 32p right now with 10k going through, according to them! hmmm!
Point taken Bakky, no offence intended.
Natdan, not my expectations, just the words of Mr Sales genomic director. I believe it will happen though!
Bakky,
'limited' capacity for testing stretches to 'tens of thousands per month', which isn't too shabby as an add on rev stream to be fair!“
Your expectations, just seven days ago.
Sorry for being the class bore, but worth repeating again the Co. strategy from the Align research note of 13 August:-
"Following the appointment of CEO Lyn Rees in summer 2018, later that year Yourgene set out its strategy to create a significant molecular genetics business and deliver material increases in shareholder value over the subsequent 3-5 years. "
Notwithstanding today's damp Covid numbers felt by many, the Co. objectives remain focused on the core elements. Growth in geographic and product penetration obviously takes time, hence the projected timetable of shareholder value expected from late 2021 onwards.
One to buy on the dips and tuck away for the (very) LTHs perhaps.
Exactly, todays update was very clear and these international sales of our clarigene test could be a real money spinner. We could end up selling millions of these as we go through the winter months.
'and there is potential for further expansion in line with anticipated demand'...….. that'll do me for starters!
'Capacity is being further expanded to 20,000 tests per month which is due to come on stream in the third quarter. This will increase COVID-19 testing revenue potential to approximately £1m per month and there is potential for further expansion in line with anticipated demand. This in-house testing uses Yourgene's own Clarigene® Sars-CoV-2 product, which is also being sold internationally through our distribution network in our channel markets and through our growing direct sales force. Regulatory submissions for Clarigene® are underway to access additional key regions and enable further geographical penetration'.
lol!! true indeed!!
For the record, majority of covid stocks down today. We are not the exception.
pmsl , still holding?
try and gain some perspective.
Florida just put it as plain as day where we are without wetting his knickers. I guess a genuine investor can articulate the state of play without the drama field BS required to try and force the price down.
Market reaction to TU gives the verdict. Period.
Not difficult to see why the verdict was down. Doesn't mean the future is over though does it. It means today's news was what it was and most wet e disappointed and or surprised at aspects not as good as could 've expected.
You have a knack for assumption, misrepresentation and getting your knickers wrapped around your ankles. Some poetic license you have.
What commission rate are you on DCooper?
I think you should be the PR company pmsl
Yeah but if an opportunity arises he can end his retirement for a buying opp pmsl
it's all about the angles!!
£1 mill a month in sideline revenue sucks !
Twix, even.
I thought Tix said he had 'retired' from this bb and wouldn't post again? hmmm!
Ygen fairing better than NYCT lol
'It doesn't look like the news of' a vaccine has impaired NCYT's share price it has to be said'
lol have you looked at their sp today? Something has spooked it!
Bakky,
spot on, we are unaffected by covid offerings coming to a halt in the future and by then we will gain huge traction on a global scale with our core business. It's good for us either way. Covid offering will provide us with good income other then next 6 months at least. Then after we still do great business with our core business.
sell twix, why you holding? you obviously see the value pmsl
I maybe a contradiction.
I can accept I perhaps have a unique take on things but I can praise when delivery deserves it.
On t h e other hand I think you are totally incapable of any critical thinking or comment. Just a yes man. That makes your views worthless Inc.
Being told today our core nipt tailed off contradicts many posters created expectations. If you can't see any fault then unlike the majority you are a paid ramper. Get real!
if a vaccine is imminent and Covid soon becomes a thing of the past which companies have got the most to lose? Most of those Covid stocks have not got a lot to fall back on. Just look where they were 9/ 12 months ago pre covid. I would be more worried if I held those stocks because a vaccine will hit them hardest . If Ygen are deemed to have missed the boat then what about some of the others who haven't even got a product anywhere near market yet.
Waspsfan
correct, we are not including any government work from the moonshot project which was more or less a sure thing going forward. so more income depending on what we can get.
I think Sorcerer summed up the confusion which is that the Company has stated that they are in talks at both a National and Local level to contribute to the moonshot testing plans. This aims at 500k tests per day whereas the capacity plans, if only based on in-house processing, has a capacity of 20k per month. Hence the confusion despite the clear statement of testing capacity. It doesn't look like the news of a vaccine has impaired NCYT's share price it has to be said perhaps because of Sor Patrick Vallance's statements to Parliament last week that a vaccine would not eradicate COVID-19 as this would just become endemic to society, like the common cold, and we would have to take tests and vaccines as part of normal course.
Yup been saying that for months and Expect to be broadly correct on vaccine. We were slow and have not been giving visible timely info and aim to ramp up to 20000 and £1 mill starting Jan. 2021. Just in time for the deceleration to start.